Michela Buscarino

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

Sandra Misale, Rona Yaeger, Sebastijan Hobor et al. · Nature · 2012 · 1.9K citations · Full text

Medicine, Molecular Genetics, Oncology +16

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

Giulia Siravegna, Benedetta Mussolin, Michela Buscarino et al. · Nature Medicine · 2015 · 1.1K citations · Full text

Medicine, Cancer Biology, Oncology +16

A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Andrea Bertotti, Giorgia Migliardi, Francesco Galimi et al. · Cancer Discovery · 2011 · 953 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer

Mariangela Russo, Giulia Siravegna, Lawrence S. Blaszkowsky et al. · Cancer Discovery · 2015 · 407 citations · Full text

Medicine, Oncology, Radiology +17

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets

Enzo Médico, Mariangela Russo, Gabriele Picco et al. · Nature Communications · 2015 · 306 citations · Full text

Medicine, Cancer Biology, Oncology +17